Delisting risk
PTPI · NASDAQ · Drug Manufacturers - Specialty & Generic

Petros Pharmaceuticals (PTPI)

Builds SaaS and SaMD tools for prescription-to-OTC drug switches.

$0.0047
At close−0.00 (−6.00%)

Something off on this page? Send us feedback.

Next report
Dec 2, 2026
estimated · in 90 days
EPS estimate
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Dec '26
Reported−$29.00−$8.46−$1.58−$0.03$8.58−$0.03−$0.30Pending
Estimate−$8.25
Surprise−251.5%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Dec '26
Reported$725.4KPending
Estimate$1.3M
Surprise−43.5%

History

DateEstimateReportedSurprise
Dec 2026
Aug 2026−$0.30
May 2026−$0.03
Apr 2026$8.58
Nov 2025−$0.03

The latest year is open to everyone — the 27 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
May 2024
Apr 2024
Nov 2023
Aug 2023
May 2023
Apr 2023
Nov 2022
Aug 2022
May 2022
Apr 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2, 2026
Aug 13, 2026−$0.30−20.6%
May 13, 2026−$0.030.0%
Apr 15, 2026$8.58+16.7%
Nov 13, 2025−$0.030.0%

The latest year is open to everyone — the 27 quarters behind it read with an account.

Sign in
Aug 14, 2025
May 15, 2025
Mar 31, 2025
Nov 13, 2024
Aug 14, 2024
May 31, 2024
May 15, 2024
Apr 1, 2024
Nov 15, 2023
Aug 14, 2023
May 15, 2023
Apr 7, 2023
Nov 15, 2022
Aug 15, 2022
May 16, 2022
Apr 1, 2022
Nov 15, 2021
Aug 17, 2021
May 17, 2021
Mar 12, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019